Schedule 13G ownership disclosure
Cytori Therapeutics Inc Com New
Security class unavailable · CUSIP: 23283K204
Event date: 2018-05-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-173578
- Form type
- SC 13G
- Filer
- PLUS THERAPEUTICS, INC.
- CIK
- CIK 1095981
- Filed
- May 24, 2018
- Reporting period
- May 10, 2018
- Description
- Schedule 13G beneficial ownership